Patent Application: 7-Cyano-8-Hydroxyquinoline Derivative Medical Use

ChangeBridge: Patent Apps - Organic Chemistry (C07D)

Published March 26th, 2026

Detected March 26th, 2026

Summary

The USPTO has published a patent application for a 7-cyano-8-hydroxyquinoline derivative, its preparation method, and its medical use in treating infectious diseases or cancer. The application details a compound with potential antibacterial, antiviral, and antitumor activity.

View original document View source feed page

What changed

This document is a patent application (US20260083721A1) filed with the USPTO, detailing a novel 7-cyano-8-hydroxyquinoline derivative. The application outlines a method for preparing this compound and its potential medical applications, specifically in the treatment of infectious diseases and cancer, citing its antibacterial, antiviral, and antitumor properties.

As this is a patent application, it does not impose direct compliance obligations on regulated entities. However, it signifies potential future developments in pharmaceutical research and intellectual property within the organic chemistry and medical fields. Companies involved in drug discovery and development, particularly in oncology and infectious diseases, may find this patent application of interest for competitive intelligence and potential licensing opportunities.

Source document (simplified)

← USPTO Patent Applications

7-CYANO-8-HYDROXYQUINOLINE DERIVATIVE, PREPARATION METHOD THEREFOR AND MEDICAL USE THEREOF

Application US20260083721A1 Kind: A1 Mar 26, 2026

Inventors

Yinun DENG, Liang WU, Haito ZHU, Chen ZHOU

Abstract

Provided are a 7-cyano-8-hydroxyquinoline derivative, a preparation method therefor and a medical use thereof specifically, disclosed are a compound represented by general formula (I), a preparation method therefor, a pharmaceutical composition containing same, and a use thereof in the treatment of infectious diseases or cancer. The compound has excellent antibacterial, antiviral and antitumor activity, and can be developed as a drug for the treatment of infectious diseases or tumors. The definitions of groups in the general formula (I) are the same as in the description.